Association between lifetime exposure to inorganic arsenic in drinking water and coronary heart disease in Colorado residents

Environmental Health Perspectives

Volumn 123, Issue 2, 2015, Pages 128-134

  James, Katherine A ^a   Byers, Tim ^a   Hokanson, John E ^a   Meliker, Jaymie R ^b   Zerbe, Gary O ^a   Marshall, Julie A ^a  

^a Food Science and Human Nutrition   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; DRINKING WATER; LOW DENSITY LIPOPROTEIN; ARSENIC; WATER POLLUTANT;

ADULT; ARSENIC POISONING; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; FEMALE; FOLLOW UP; GLUCOSE TOLERANCE; HUMAN; HYPERTENSION; ION EXCHANGE CHROMATOGRAPHY; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MIDDLE AGED; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; TRIACYLGLYCEROL BLOOD LEVEL; AGED; CHEMISTRY; CORONARY DISEASE; TOXICITY; UNITED STATES; URINE; WATER POLLUTANT;

ADULT; AGED; ARSENIC; COHORT STUDIES; COLORADO; CORONARY DISEASE; DRINKING WATER; FEMALE; HUMANS; MALE; MIDDLE AGED; WATER POLLUTANTS, CHEMICAL;

EID: 84922962152     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1307839     Document Type: Article

References (54)

1. Abernathy CO, Thomas DJ, Calderon RL. 2003. Health effects and risk assessment for arsenic. J Nutr 133(5 suppl 1):1536S-1538S.
2. Abhyankar LN, Jones MR, Guallar E, Navas-Acien A. 2012. Arsenic exposure and hypertension: a systematic review. Environ Health Perspect 120:494-500; doi:10.1289/ehp.1103988.
3. Agency for Toxic Substances and Disease Registry. 2007. Toxicological Profile for Arsenic (Update). Atlanta, GA:U.S. Department of Health and Human Services, Public Health Service. Available: http:// www.atsdr.cdc.gov/ToxProfiles/tp2.pdf[accessed 12 January 2015].
4. Ayotte JD, Nolan BT, Nuckols JR, Cantor KP, Robinson GR Jr, Baris D, et al. 2006. Modeling the probability of arsenic in groundwater in New England as a tool for exposure assessment. Environ Sci Technol 40(11):3578-3585.
5. Bae ON, Lim EK, Lim KM, Noh JY, Chung SM, Lee MY, et al. 2008. Vascular smooth muscle dysfunction induced by monomethylarsonousacid (MMAIII): a contributing factor to arsenic-associated cardio-vascular diseases. Environ Res 108:300-308.
6. Barlow WE, Ichikawa L, Rosner D, Izumi S. 1999. Analysis of case-cohort designs. J Clin Epidemiol 52(112):1165-1172.
7. Chen CJ, Chiou HY, Chiang MH, Lin LJ, Tai TY. 1996. Dose-response relationship between ischemic heart disease mortality and long-term arsenic exposure. Arterioscler Thromb Vasc Biol 16:504-510.
8. Chen CJ, Hsueh YM, Lai MS, Shyu MP, Chen SY, Wu MM, et al. 1995. Increased prevalence of hypertension and long-term arsenic exposure. Hypertension 25(1):53-60.
9. Chen CJ, Wang SL, Chiou JM, Tseng CH, Chiou HY, Hsueh YM, et al. 2007. Arsenic and diabetes and hypertension in human populations: a review. Toxicol Appl Pharmacol 222:298-304.
10. Chen Y, Factor-Litvak P, Howe GR, Graziano JH, Brandt- Rauf P, Parvex F, et al. 2006a. Arsenic exposure from drinking water, dietary intakes of B vitamins and folate, and risk of high blood pressure in Bangladesh: a population-based, cross-sectional study. Am J Epidemiol 165(5):541-552.
11. Chen Y, Graziano JH, Parvez F, Liu M, Slavkovich V, Kalra T, et al. 2011. Arsenic exposure from drinking water and mortality from cardiovascular disease in Bangladesh: prospective cohort study. BMJ 342:d2431; doi:10.1136/bmj.d2431.
12. Chen Y, Hakim ME, Parvez F, Islam T, Rahman AM, Ahsan H. 2006b. Arsenic exposure from drinking- water and carotid artery intima-medial thickness in healthy young adults in Bangladesh. J Health Popul Nutr 24(2):253-257.
13. Chen Y, Parvez F, Gamble M, Islam T, Ahmed A, Argos M, et al. 2009. Arsenic exposure at low-to- moderate levels and skin lesions, arsenic metabo-lism, neurological functions, and biomarkers for respiratory and cardiovascular diseases: review of recent findings from the Health Effects of Arsenic Longitudinal Study (HEALS) in Bangladesh. Toxicol Appl Pharmacol 239(2):184-192.
14. Chen Y, Wu F, Parvez F, Ahmed A, Eunus M, McClintock TR, et al. 2013. Arsenic exposure from drinking water and QT-interval prolonga-tion: results from the Health Effects of Arsenic Longitudinal Study. Environ Health Perspect 121:427-432; doi:10.1289/ehp.1205197.
15. Engel RR, Hopenhayn-Rich C, Receveur O, Smith AH. 1994. Vascular effects of chronic arsenic exposure: a review. Epidemiol Rev 16(2):184-209.
16. Engel RR, Smith AH. 1994. Arsenic in drinking water and mortality from vascular disease: an ecologic analysis in 30 countries in the United States. Arch Environ Health 49(5):418-427.
17. Friedewald WT, Levy RI, Frederickson DS. 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502.
18. George CM, Gamble M, Slavkovich V, Levy D, Ahmed A, Ahsan H, et al. 2013. A cross-sectional study of the impact of blood selenium on blood and urinary arsenic concentrations in Bangladesh. Environ Health 12:52; doi:10.1186/1476-069X-12-52.
19. Hamman RF, Marshall JA, Baxter J, Kahn LB, Mayer EJ, Orleans M, et al. 1989. Methods and prevalence of non-insulin-dependent diabetes mellitus in a biethnic Colorado population. The San Luis Valley Diabetes Study. Am J Epidemiol 159(2):295-311.
20. Hinwood AL, Sim MR, Jolley D, de Klerk N, Bastone EB, Gerostamoulos J, et al. 2003. Risk factors for increased urinary inorganic arsenic concentrations from low arsenic concentrations in drinking water. Int J Environ Health Res 13(3):271-284.
21. Hirano S, Cui X, Li S, Kanno S, Kobayashi Y, Hayakawa T, et al. 2003. Difference in uptake and toxicity of trivalent and pentavalent inorganic arsenic in rate heart microvessel endothelial cells. Arch Toxicol 77:305-312.
22. Hokanson JH, Kamboh MI, Scarboro S, Eckel RH, Hamman RF. 2003. Effects of the hepatic lipase gene and physical activity on coronary heart disease risk. Am J Epidemiol 158(9):836-843.
23. James KA, Meliker JR, Buttenfield BE, Byers T, Zerbe GO, Hokanson JE, et al. 2014. Predicting arsenic concentrations in groundwater of San Luis Valley, Colorado: implications for individual-level lifetime exposure assessment. Environ Geochem Health 36(4):773-782.
24. James KA, Meliker JR, Marshall JA, Hokanson JE, Zerbe GO, Byers TE. 2013. Validation of estimates of past exposure to arsenic in drinking water using historical urinary arsenic concentrations. J Expo Sci Environ Epidemiol 23(4):450-454.
25. Kao YH, Yu CL, Chang LW, Yu HS. 2003. Low concentrations of arsenic induce vascular endothelial growth factor and nitric oxide release and stimulate angiogenesis in vitro. Chem Res Toxicol 16:460-468.
26. Lee MY, Bae ON, Chung SM, Kang KT, Lee JY, Chung JH. 2002. Enhancement of platelet aggregation and thrombus formation by arsenic in drinking water: a contributing factor to cardiovascular disease. Toxicol Appl Pharmacol 179:83-88.
27. Lee MY, Jung BI, Chung SM, Bae ON, Lee JY, Park JD, et al. 2003. Arsenic-induced dysfunction in relaxa-tion of blood vessels. Environ Health Perspect 111:513-517; doi:10.1289/ehp.5916.
28. Lewis DR, Southwick JW, Ouellet-Hellstrom R, Rench J, Calderon RL. 1999. Drinking water arsenic in Utah: a cohort mortality study. Environ Health Perspect 107:359-365.
29. Lin TH, Huang LY. 1995. Chemical speciation of arsenic in urine of patients with blackfoot disease. Biol Trace Elem Res 48(3):251-261.
30. Mayer EJ, Alderman BW, Regensteiner JG, Marshall JA, Haskell WL, Baxter J, et al. 1991. Physical-activity- assessment measures compared in a biethnic rural population: the San Luis Valley Diabetes Study. Am J Clin Nutr 53:812-820.
31. Medrano MA, Boix R, Pastor-Barriuso R, Palau M, Damián J, Ramis R, et al. 2010. Arsenic in public water supplies and cardiovascular mortality in Spain. Environ Res 110:448-454.
32. Meliker JR, Goovaerts P, Jacquez GM, Nriagu JO. 2010. Incorporating individual-level distributions of exposure error in epidemiologic analyses: an example using arsenic in drinking water and bladder cancer. Ann Epidemiol 20(10):750-758.
33. Meliker JR, Wahl RL, Cameron LL, Nriagu JO. 2007. Arsenic in drinking water and cerebrovascular disease, diabetes mellitus, and kidney disease in Michigan: a standardized mortality ratio analysis. Environ Health 6:4; doi:10.1186/1476-069X-6-4.
34. Moon KA, Guallar E, Umans JG, Devereux RB, Best LG, Francesconi KA, et al. 2013. Association between exposure to low to moderate arsenic levels and incident cardiovascular disease. Ann Int Med 159(10):649-659.
35. Navas-Acien A, Sharrett AR, Silbergeld EK, Schwartz BS, Nachman KE, Burke TA, et al. 2005. Arsenic exposure and cardiovascular disease: a systemic review of the epidemiologic evidence. Am J Epidemiol 162(11):1037-1049.
36. Neely KW. 2002. Idaho Department of Water Resources. Technical Summary. Arsenic Results from Statewide Program, 1991-2001. Available: http://www.idwr.idaho.gov/WaterInformation/Publications/wib/wib50p5-arsenic_1991-2001.pdf [accessed 9 September 2008].
37. Pi J, Yamauchi H, Kumagai Y, Sun G, Yoshida T, Aikawa H, et al. 2002. Evidence for induction of oxidative stress caused by chronic exposure of Chinese residents to arsenic contained in drinking water. Environ Health Perspect 110:331-336.
38. Rahman M, Tondel M, Ahmad SA, Chowdhury IA, Faruquee MH, Axelson O. 1999. Hypertension and arsenic exposure in Bangladesh. Hypertension 33:74-78.
39. Ratnaike RN. 2003. Acute and chronic arsenic toxicity. Postgrad Med J 79:391-396.
40. Santra A, Maiti A, Chowdhury A, Mazumder DN. 2000. Oxidative stress in liver of mice exposed to arsenic-contaminated water. Indian J Gastroenterol 19(3):112-115.
41. Simeonova PP, Luster MI. 2004. Arsenic and athero-sclerosis. Toxicol Appl Pharmacol 198:444-449.
42. Sohel N, Persson LA, Rahman M, Streatfield PK, Yunus M, Ekström EC, et al. 2009. Arsenic in drinking water and adult mortality: a population-based cohort study in rural Bangladesh. Epidemiology 20:824-830.
43. Steinmaus CM, Yuan Y, Smith AH. 2005. The temporal stability of arsenic concentrations in well water in western Nevada. Environ Res 99(2):164-168.
44. Swenson CJ, Trepka MJ, Rewers MJ, Scarbro S, Hiatt WR, Hamman RF. 2001. Cardiovascular disease mortality in Hispanics and non-Hispanic whites. Am J Epidemiol 156(10):919-928.
45. Tao SS, Bolger PM. 1999. Dietary arsenic intakes in the United States. FDA Total Diet Study, September-1991 December 1996. Food Addit Contam 16:465-472.
46. Tseng CH, Chong CK, Tseng CP, Hsueh YM, Chiou HY, Tseng CC, et al. 2003. Long term arsenic exposure and ischemic heart disease in arseniasis-hyperen-demic villages in Taiwan. Toxicol Lett 137:15-21.
47. U.S. EPA (U.S. Environmental Protection Agency). 1998. Arsenic, Inorganic (CASRN 7440-38-2). Available: http://www.epa.gov/IRIS/subst/0278.htm [accessed 12 January 2015].
48. U.S. EPA (U.S. Environmental Protection Agency). 2011. Arsenic in Drinking Water. Available: http://water.epa.gov/lawsregs/rulesregs/sdwa/arsenic/index.cfm [accessed 1 March 2011].
49. Waalkes MP, Fox DA, States JC, Patierno SR, McCabe MJ Jr. 2000. Metals and disorders of cell accumulation: modulation of apoptosis and cell proliferation. Toxicol Sci 56:255-261.
50. Wang CH, Chen CL, Hsiao CK, Chiang FT, Hsu LI, Chiou HY, et al. 2010. Arsenic-induced QT dispersion is associated with atherosclerotic diseases and predicts long-term cardiovascular mortality in subjects with previous exposure to arsenic: a 17-year follow-up study. Cardiovasc Toxicol 10(1):17-26.
51. Wang CH, Hsiao CK, Chen CL, Hsu LI, Chiou HY, Chen SY, et al. 2007. A review of the epidemiologic literature on the role of environmental arsenic exposure and cardiovascular diseases. Toxicol Appl Pharmacol 222:315-326.
52. Wang CH, Jeng JS, Yip PK, Chen CL, Hsu LI, Hsueh YM, et al. 2002. Biological gradient between long-term arsenic exposure and carotid atherosclerosis. Circulation 105:1804-1809.
53. Yamanaka K, Hoshino M, Okamoto M, Sawamura R, Hasegawa A, Okada S. 1990. Induction of DNA damage by dimethylarsenic, a metabolite of inorganic arsenics, is for the major part likely due to its peroxyl radical. Biochem Biophys Res Commun 168(1):58-64.
54. Zierold KM, Knobeloch L, Anderson H. 2004. Prevalence of chronic diseases in adults exposed to arsenic-contaminated drinking water. Am J Public Health 94:1936-1937.